NCT00811083View on ClinicalTrials.gov

Dimercaptosuccinic Acid (DMSA) Treatment of Children With Autism and Heavy Metal Toxicity

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Autism
Interventions
DRUG

DMSA - dimercaptosuccinic acid

dose of 10 mg/kg bodyweight 3 doses/day, for 3 days, followed by 11 days off

Trial Locations (1)

85252

Southwest College of Naturopathic Medicine, Tempe

All Listed Sponsors
lead

Southwest College of Naturopathic Medicine

OTHER

NCT00811083 - Dimercaptosuccinic Acid (DMSA) Treatment of Children With Autism and Heavy Metal Toxicity | Biotech Hunter | Biotech Hunter